{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:20:07Z","timestamp":1649107207689},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T00:00:00Z","timestamp":1249516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s12328-009-0101-0","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T04:23:59Z","timestamp":1249446239000},"page":"346-350","source":"Crossref","is-referenced-by-count":1,"title":["A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy"],"prefix":"10.1007","volume":"2","author":[{"given":"Yusuke","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,6]]},"reference":[{"key":"101_CR1","first-page":"147","volume":"26","author":"A John","year":"2007","unstructured":"John A, El Emadi S, Al Kaabi S, et al. Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis. Indian J Gastroenterol. 2007;26:147\u20138.","journal-title":"Indian J Gastroenterol"},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2165\/00003495-200161150-00013","volume":"61","author":"CM Perry","year":"2001","unstructured":"Perry CM, Jarvis B. Peginterferon-alpha-2a (40\u00a0kD): a review of its use in the management of chronic hepatitis C. Drugs. 2001;61:2263\u201388.","journal-title":"Drugs"},{"key":"101_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00003495-200363070-00008","volume":"63","author":"GM Keating","year":"2003","unstructured":"Keating GM, Curran MP. Peginterferon-alpha-2a (40\u00a0kD) plus ribavirin: a review of its use in the management of chronic hepatitis C. Drugs. 2003;63:701\u201330.","journal-title":"Drugs"},{"key":"101_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet. 2001;358:958\u201365.","journal-title":"Lancet"},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2036.2007.03294.x","volume":"25","author":"M Simin","year":"2007","unstructured":"Simin M, Brok J, Stimac D, et al. Cochrane systematic review: pegylated interferon plus ribavirin vs interferon plus ribavirin for chronic hepatitis C. Aliment Pharmacol Ther. 2007;25:1153\u201362.","journal-title":"Aliment Pharmacol Ther"},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2005.06.010","volume":"37","author":"G Venezia","year":"2005","unstructured":"Venezia G, Bicata A, Di Marco V, et al. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Dig Liver Dis. 2005;37:882\u20135.","journal-title":"Dig Liver Dis"},{"key":"101_CR7","first-page":"22","volume":"36","author":"H Iguchi","year":"1996","unstructured":"Iguchi H, Kishi M, Fujioka T, et al. Polymyositis after interferon beta treatment of chronic hepatitis type C. Rinsho Shinkeigaku. 1996;36:22\u20134.","journal-title":"Rinsho Shinkeigaku"},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2169\/internalmedicine.33.806","volume":"33","author":"M Matsuya","year":"1994","unstructured":"Matsuya M, Abe T, Tosaka M, et al. The first case of polymyositis associated with interferon therapy. Intern Med. 1994;33:806\u20138.","journal-title":"Intern Med"},{"key":"101_CR9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(95)90490-5","volume":"345","author":"H Arai","year":"1995","unstructured":"Arai H, Tanaka M, Ohta K, et al. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet. 1995;345:582.","journal-title":"Lancet"},{"key":"101_CR10","first-page":"441","volume":"45","author":"Y Nagane","year":"2005","unstructured":"Nagane Y, Utsugisawa K, Kizawa H, et al. Hypothyroid myopathy caused by interferon-alpha therapy for chronic hepatitis C. Rinsho Shinkeigaku. 2005;45:441\u20134.","journal-title":"Rinsho Shinkeigaku"},{"key":"101_CR11","unstructured":"Kouno H, Aimitsu S, Ikemoto Y, et al. Cardiovascular complications of interferon therapy in chronic hepatitis C. Nippon Rinsho. 1994;52:1914\u20138."},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/BOR.0b013e3282efe261","volume":"19","author":"SA Greenberg","year":"2007","unstructured":"Greenberg SA. A gene expression approach to study perturbed pathways in myositis. Curr Opin Rheumatol. 2007;19:536\u201341.","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-009-0101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-009-0101-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-009-0101-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:56:13Z","timestamp":1559447773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-009-0101-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,6]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s12328-009-0101-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,6]]}}}